These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7513876)

  • 21. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia.
    Antz M; Cappato R; Kuck KH
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):627-35. PubMed ID: 8569226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
    Kehoe RF; MacNeil DJ; Zheutlin TA; Ezri MD; Nazari J; Spangenberg RB; Dunnington C; Lueken M
    Am J Cardiol; 1993 Aug; 72(4):56A-66A. PubMed ID: 8346728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V; Mermi J; Mewis C; Seipel L
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
    Hoppe UC; Haverkamp W; Breithardt G; Borggrefe M
    Pacing Clin Electrophysiol; 2000 May; 23(5):854-62. PubMed ID: 10833706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's.
    Capucci A; Aschieri D; Villani GQ
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():57-63. PubMed ID: 10590490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic Study versus Electrocardiographic Monitoring (ESVEM): a critical appraisal.
    Prystowsky EN
    Control Clin Trials; 1996 Jun; 17(3 Suppl):28S-36S. PubMed ID: 8877265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A perspective on the ESVEM trial current knowledge: sotalol should not be the first-line agent in the management of ventricular arrhythmias.
    Garan H
    Prog Cardiovasc Dis; 1996; 38(6):455-6. PubMed ID: 8638026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolving role of sotalol in the management of ventricular tachyarrhythmias.
    O'Callaghan PA; McGovern BA
    Am J Cardiol; 1996 Aug; 78(4A):54-60. PubMed ID: 8780329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and chronic antiarrhythmic efficacy of d-sotalol in patients with sustained ventricular tachyarrhythmias.
    Brachmann J; Schöls W; Beyer T; Montero M; Enders B; Kübler W
    Eur Heart J; 1993 Nov; 14 Suppl H():85-7. PubMed ID: 8293757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
    Finance O; Manning A; Chatelain P
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):570-6. PubMed ID: 8569217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
    Dorian P; Newman D; Berman N; Hardy J; Mitchell J
    J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study.
    Gelzer AR; Kraus MS; Rishniw M; Hemsley SA; Moïse NS
    J Vet Cardiol; 2010 Aug; 12(2):93-106. PubMed ID: 20663731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sotalol for ventricular tachyarrhythmias: beta-blocking and class III contributions, and relative efficacy versus class I drugs after prior drug failure. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiffel JA; Hahn E; Hartz V; Reiter MJ
    Am J Cardiol; 1997 Apr; 79(8):1048-53. PubMed ID: 9114762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of reproducibility of baseline arrhythmia induction on drug efficacy predictions and outcome in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial.
    Mann DE; Hartz V; Hahn EA; Reiter MJ
    Am J Cardiol; 1997 Dec; 80(11):1448-52. PubMed ID: 9399720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators.
    Olshansky B; Hahn EA; Hartz VL; Prater SP; Mason JW
    Am Heart J; 1999 May; 137(5):878-86. PubMed ID: 10220637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
    Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.